Urine Metabolite Levels, Adverse Kidney Outcomes, and Mortality in CKD Patients: A Metabolome-wide Association StudyInga Steinbrenner, Britta Bauer, Markus P. Schneider et al.|American Journal of Kidney Diseases|2021Cited by 42
Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohortKatharina C. Reimer, Peter J. Oefner, Jennifer Nadal et al.|Bone Research|2023Cited by 22
Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort StudyMarkus P. Schneider, Hansi Weißensteiner, Matthias Schmid et al.|American Journal of Kidney Diseases|2022Cited by 10
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKDClaudia Sommerer, Antje Börner-Klein, Sandra Müller-Krebs et al.|Kidney International Reports|2023Cited by 5
Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD studyBarbara Kollerits, Peter J. Oefner, Simon Gruber et al.|BMC Cancer|2024Cited by 3